Miraboutalebi S A, Dehghani Ashkezari M, Seifati S M
Islamic Azad University, Ashkezar Branch, Medical Biotechnology Research Center, Department of Biology, Ashkezar, Yazd, Iran.
Acta Endocrinol (Buchar). 2024 Jan-Mar;20(1):33-38. doi: 10.4183/aeb.2024.33. Epub 2024 Oct 3.
The exact pathogenesis of the endometriosis is not apparent. MicroRNAs (miRNAs/miRs) are non-coding RNAs that regulate gene expression at the post-transcriptional level. MicroRNAs can be used a diagnostic and therapeutic tools in different disorders such as endometriosis. MiR-181 has a function in embryo implantation. The main aim of this study is to evaluate the expression of miR-181 and its relationship with HOXA11 gene expression in ectopic and eutopic endometrium tissues in women with endometriosis.
Thirty-four women participated in this study. Ectopic tissue samples (N=17) were collected via laparoscopic surgery, and eutopic tissue samples (N=17) were obtained from an endometrial biopsy. Endometrial tissue samples without endometriosis were considered the control group. Tissue samples were placed in RNase-free microtube with RNAlater™ Stabilization Solution (Thermo Fisher Scientific) and were kept at -80 °C. Quantitative real time-PCR for MiR-181 and HOXA11 genes were performed.
MiR-181 expression level increased in eutopic tissue samples compared to the control group. This expression showed a significantly decrease in an ectopic group compared to the eutopic group. It was observed that HOXA11expression decreased remarkably in eutopic group compared to the control group and increased in ectopic group compared to the eutopic group.
MiR-181 and HOXA11 are promising strategies in endometriosis disease. Understanding this relation and regulation roles contribute to realizing the etiology of endometriosis.
子宫内膜异位症的确切发病机制尚不清楚。微小RNA(miRNA/miR)是在转录后水平调节基因表达的非编码RNA。微小RNA可作为子宫内膜异位症等不同疾病的诊断和治疗工具。MiR-181在胚胎植入中发挥作用。本研究的主要目的是评估MiR-181在子宫内膜异位症患者异位和在位子宫内膜组织中的表达及其与HOXA11基因表达的关系。
34名女性参与了本研究。通过腹腔镜手术收集异位组织样本(n = 17),并从子宫内膜活检中获取在位组织样本(n = 17)。无子宫内膜异位症的子宫内膜组织样本被视为对照组。将组织样本置于含有RNAlater™稳定溶液(赛默飞世尔科技公司)的无RNase微管中,并保存在-80°C。对MiR-181和HOXA11基因进行定量实时PCR。
与对照组相比,在位组织样本中MiR-181表达水平升高。与在位组相比,异位组的这种表达显著降低。观察到,与对照组相比,在位组中HOXA11表达显著降低,与在位组相比,异位组中HOXA11表达升高。
MiR-181和HOXA11是子宫内膜异位症疾病中有前景的研究方向。了解这种关系和调节作用有助于认识子宫内膜异位症的病因。